1. Abramson, H.A., Sklarofsky, B., Baron, M.O., Fremont-Smith, N.: Lysergic acid diethylamide (LSD-25) antagonists. II. Development of tolerance in man to LSD-25 by prior administration of MLD-41 (1-methyl-d-lysergic acid diethylamide). Arch. Neurol. Psychiat. 79, 201–207 (1958)
2. Aghajanian, G.K., Bing, O.H.L.: Persistence of lysergic acid diethylamide in the plasma of human subjects. Clin. Pharmacol. Ther. 5, 611–614 (1964)
3. Aghajanian, G.K., Haigler, H.J., Bennett, J.L.: Amine receptors in CNS III. 5-hydroxytrypta- mine in brain. In: Handbook of Psychopharmacology, 6, ED. Iverson, L.L., Iversen, S.D., Snyder, S.H. (eds.), pp. 63–96 New York: Plenum Press 1975
4. Aghajanian, G.K., Wang, R.Y.: Physiology and pharmacology of central serotonergic neurons. In: Psychopharmacology: A generation of progress. Lipton, M.A., Dimascio, A., Killam, K.F. (eds.), pp. 171–183, New York: Raven Press 1978
5. Ahn, H.S., Makman, M.H.: Interaction of LSD and other hallucinogens with dopamine-sensitive adenylate cyclase in primate brain: regional differences. Brain Res. 162, 77–78 (1979)